Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002783 · ClinicalTrials.gov registry record · Phase 2
Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00002783: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00002783 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002783, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy before and after surgery in treating patients with high-risk stomach cancer.
Interventions
- DRUG cisplatin
- DRUG fluorouracil
- DRUG leucovorin calcium
- PROCEDURE conventional surgery
- DRUG floxuridine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 1996-05 |
| Est. Completion | 2001-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002783
The ClinicalTrials.gov registry entry for NCT00002783 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00002783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002783 about?
NCT00002783 is a clinical study titled "Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy before and after surge...
What is the current status of trial NCT00002783?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 1996-05. Estimated completion is 2001-01.
What interventions are being tested in trial NCT00002783?
The interventions under investigation include: cisplatin (DRUG), fluorouracil (DRUG), leucovorin calcium (DRUG), conventional surgery (PROCEDURE), floxuridine (DRUG).
Who is sponsoring clinical trial NCT00002783?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.